The Rising Tide of PBM Regulation: What Pharmacies and Patients Need to Know
West Virginia’s recent $1.5 million penalty against Express Scripts signals a growing trend: increased scrutiny of pharmacy benefit managers (PBMs) by state regulators. This action, following a detailed market conduct examination, isn’t an isolated incident. Several states are now actively investigating PBM practices related to reimbursement, rebates, and relationships with pharmacies and health plans.
Why the Sudden Focus on PBMs?
For years, PBMs have operated with a degree of opacity, acting as intermediaries between drug manufacturers, insurance companies, and pharmacies. Concerns have mounted regarding their impact on drug prices and access to care. Regulators are responding to these concerns, aiming to ensure fair practices and protect both pharmacies and patients.
Key Areas of Regulatory Scrutiny
The West Virginia case highlights several critical areas now under the regulatory microscope:
- Pharmacy Reimbursement Rates: Ensuring pharmacies are reimbursed fairly, typically based on the National Average Drug Acquisition Cost (NADAC) plus a dispensing fee.
- Rebate Transparency: Demanding clarity on how rebates from drug manufacturers are handled and whether they are being passed on to consumers.
- PBM-Affiliated Pharmacies: Preventing preferential treatment for pharmacies owned by or affiliated with the PBM, which can create unfair competition.
- Pharmacy Audits: Limiting the scope and fairness of pharmacy audits, preventing excessive recoupments.
- Cost-Sharing for Medications: Enforcing caps on patient cost-sharing, particularly for essential medications like insulin.
- Network Adequacy: Requiring PBMs to maintain accurate and up-to-date pharmacy networks.
The Impact on Pharmacies
Independent and community pharmacies are often the most vulnerable to unfair PBM practices. The West Virginia case revealed instances of underpayment and non-refundable fees imposed on pharmacies. Increased regulatory scrutiny offers pharmacies potential avenues to challenge these practices and seek redress. Pharmacies should proactively review their contracts and reimbursement arrangements to ensure compliance with state laws.
What Does This Mean for Patients?
stricter PBM regulation aims to benefit patients by lowering drug costs and improving access to medications. The West Virginia case specifically addressed violations related to insulin cost-sharing, resulting in overpayments by consumers. Greater transparency and fair reimbursement practices can translate to lower premiums and out-of-pocket expenses for patients.
Beyond West Virginia: A National Trend
The Federal Trade Commission (FTC) is as well actively investigating PBM practices. In February 2026, the FTC reached a deal with Express Scripts regarding insulin pricing, requiring the PBM to increase transparency and restructure compensation. This federal action, alongside state-level enforcement, demonstrates a coordinated effort to address concerns about PBM accountability.
The Future of PBM Regulation
Expect to observe continued expansion of state-level PBM regulation. States are likely to focus on:
- Standardizing Reimbursement Methodologies: Adopting consistent rules for calculating pharmacy reimbursement rates.
- Mandating Rebate Pass-Through: Requiring PBMs to pass on a greater portion of manufacturer rebates to patients and health plans.
- Increasing Transparency: Demanding more detailed reporting on PBM operations and financial relationships.
- Strengthening Audit Protections: Implementing safeguards to prevent unfair or excessive pharmacy audits.
Did you know? The West Virginia examination covered Express Scripts’ operations from January 1, 2023, to June 1, 2024, highlighting the lengthy timeframe regulators are willing to investigate.
FAQ
Q: What is a PBM?
A: A Pharmacy Benefit Manager manages prescription drug benefits on behalf of health plans and employers.
Q: What is NADAC?
A: The National Average Drug Acquisition Cost is a benchmark used to determine pharmacy reimbursement rates.
Q: How can pharmacies protect themselves?
A: Review contracts, document reimbursement discrepancies, and stay informed about state PBM regulations.
Q: Will these changes lower my prescription costs?
A: Potentially, yes. Increased transparency and fair reimbursement practices can lead to lower drug prices for consumers.
Pro Tip: Pharmacies should consult with legal counsel specializing in PBM regulations to ensure full compliance.
Stay informed about the evolving landscape of PBM regulation. Explore additional resources on pharmacy law and healthcare policy to understand your rights and advocate for fair practices.
